Coronavirus News LIVE Updates: The Subject Expert Committee (SEC) of the national drug regulator on Saturday recommended that Bharat Biotech Covid-19 vaccine applicant Covaxin be approved for restricted emergency use in India, the union health ministry said. The locally-made vaccine is the second to get the expert panel's nod, after the Oxford-AstraZeneca shot was given clearance on Friday evening.
Confirming the accelerated approval, the ministry said that the SEC has granted permission to Covaxin for restricted use in emergency situations "in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains". The committee constituted by Central Drug Standard Control Organisation had on Friday maintained that the data provided by Bharat Biotech for its coronavirus vaccine was not sufficient for grant of emergency use approval and had asked for more information, but granted its recommendation on Saturday.
Covid-19 Vaccination Dry Run | A mock drill on Covid-19 vaccine administration was held in all states and Union Territories at 286 session sites spread across 125 districts. Around 1,14,100 vaccinators were trained. More than 75 lakhs beneficiaries have been registered on Co-WIN software till date, says Government of India.
Odisha government Saturday announced that schools will reopen for students of standards X and XII from January 8 and will follow the detailed standard operating procedure to be strictly implemented by…
In these unprecedented times, cricket has resumed but has resumed on a tight leash.
Jan 02, 2021 19:37 (IST)
Britain Will Allow Mixing of Covid-19 Vaccines on Rare Occasions | Britain will allow people to be given shots of different Covid-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses. In a departure from other strategies globally, the government said people could be given a mix-and-match of two Covid-19 shots, for example if the same vaccine dose was out of stock, according to guidelines published on New Year’s Eve, reports Reuters.
Jan 02, 2021 19:27 (IST)
Permission Granted for Retricted Use in Emergency Situation to Bharat Biotech | "Grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains, to M/s Bharat Biotech International Ltd., Hyderabad," statement by Union Health Ministry reads.
Jan 02, 2021 19:19 (IST)
Karnataka Covid-19 Cases Update | Karnataka reported 755 new Covid-19 cases, 976 discharges and 3 deaths today.
Karnataka reported 755 new #COVID19 cases, 976 discharges and 3 deaths today.
All India Institute of Medical Sciences (AIIMS) Director Dr.
Jan 02, 2021 18:40 (IST)
Covaxin Gets Expert Panel's Clearance for India | CDSCO panel recommends granting approval for restricted emergency use of Bharat Biotech's indigenous Covid-19 vaccine Covaxin in India: Sources
Jan 02, 2021 18:28 (IST)
Omar Abdullah Speaks on Controversy Over Covid-19 Vaccine | Amid ongoing controversy over SP chief Akhilesh Yadav's "BJP's Covid-19 vaccine" statement, National Conference leader Omar Abdullah tweeted, "I don’t know about anyone else but when my turn comes I’ll happily roll up my sleeve and get a Covid-19 vaccine. This damn virus has been far too disruptive and if a vaccine helps bring about a semblance of normalcy after all the chaos then sign me up."
I don’t know about anyone else but when my turn comes I’ll happily roll up my sleeve & get a COVID vaccine. This damn virus has been far too disruptive & if a vaccine helps bring about a semblance of normalcy after all the chaos then sign me up. https://t.co/bVOw7lPJ6w
Union Health Minister Harsh Vardhan appealed to people on Saturday not to be misguided by "rumours" and disinformation campaigns regarding the safety and efficacy of the coronavirus vaccine, stressing…
Without taking names, State Health Minister Vishwajit Rane on Saturday slammed Goa MLAs and Ministers for exerting pressure on health department officials and government doctors to prematurely…
Jan 02, 2021 17:49 (IST)
Ready for Vaccine Rollout Within Next Few Days: Dr. Randeep Guleria | "I feel we are ready for a vaccine rollout within the next 10 to 14 days in a smooth manner. We will start the vaccination in a slow process, by that time more vaccines will be available," says AIIMS Director Dr. Randeep Guleria.
I feel we are ready for a Vaccine rollout within the next 10 to 14 days in a smooth manner. We will start the vaccination in a slow process, by that time more vaccines will be available: AIIMS Director Dr. Randeep Guleria tells @shreyadhoundialpic.twitter.com/NnUWhxtUCi
The UK government has instructed all primary schools in London to remain closed and not return for the new term on Monday amid a surge in COVID-19 infections rates across England.
Jan 02, 2021 17:14 (IST)
Prakash Javadekar Speaks on Covid-19 Vaccine | "India is perhaps the only country where four vaccines are getting ready. Serum Institute of India's Covishield was yesterday approved for emergency use," says Union Minister Prakash Javadekar.
More than 10% of Israel’s population has received a first dose of a coronavirus vaccine, a rate that has far outstripped the rest of the world and buoyed the battered domestic image of the country’s…
Jan 02, 2021 16:35 (IST)
Anurag Thakur on Akhilesh Yadav's Statement | "Akhilesh Yadav's statement that he 'won't get vaccinated as it's a BJP vaccine' is very unfortunate...What can be more unfortunate than a young leader linking Covid-19 vaccine with a political party. It shows Akhilesh Yadav can't think above politics," says MoS Finance and BJP leader Anurag Thakur.
Akhilesh Yadav's statement that he 'won't get vaccinated as it's a BJP vaccine' is very unfortunate...What can be more unfortunate than a young leader linking #COVID19 vaccine with a political party. It shows Akhilesh Yadav can't think above politics: Anurag Thakur, MoS Finance https://t.co/dyQToL2kVkpic.twitter.com/OBvUEXcGy0
SEC Meeting Concludes | The meeting of the Subject Expert Committee (SEC) has now concluded. The meeting lasted for 40 minutes. The decision on Bharat Biotech's Covid-19 vaccine applicant, Covaxin, is awaited.
Delhi recorded 494 fresh COVID-19 cases on Saturday, the lowest daily rise in over seven months, and 14 new fatalities, while the positivity rate remained unchanged at 0.
Jan 02, 2021 15:50 (IST)
Delhi Govt Announces Free Covid-19 Vaccine for People | The Delhi government today announced free Covid-19 vaccine doses to people in the capital city while and ensured the inoculation of one lakh people on a regular basis soon after it receives it from the Centre. Delhi Health Minister Satyendar Jain made the announcement while reviewing the dry run of the Covid vaccination process at the Daryaganj dispensary in Central Delhi.
Covaxin has been developed by Hyderabad-based Bharat Biotech.
Union minister Prakash Javadekar on Saturday said India is perhaps the only country which is getting ready with four vaccines against Covid-19. India is currently considering the applications of three vaccine candidates - Oxford-Astrazeneca, Pfizer and Bharat Biotech - and the minister implied that more than one vaccine is likely to get approval for emergency use.
India is staging nationwide drills today to start one of the world's biggest coronavirus vaccination programmes after a government panel on Friday recommended emergency use of the AstraZeneca-Oxford University shot. The first injections could be given in the coming week after the Drugs Control Authority of India gives final approval. The expert panel met again on Saturday to consider the vaccine candidate of Bharat Biotech and a decision on Covaxin is awaited.
India, which has the world's second highest number of pandemic cases -- more than 10.2 million -- has set an ambitious target of inoculating 300 million of its 1.3 billion people by mid-2021. Serum Institute of India, the world's biggest vaccine producer, has already stockpiled tens of millions of doses of AstraZeneca's Covishield ready for the campaign and 96,000 health workers have been trained for the inoculation drive. The drills saw 25 health workers receive dummy vaccines at each of the centres to be used across the country in a test run ahead of the launch.
Health minister Harsh Vardhan said the exercise would help build expertise "so that the upcoming vaccination drive may proceed without any glitch." He has also called for a campaign to counter "misleading rumours" that may scare people off getting the vaccine. While India is only second to the United States for the number of cases, its rate of infection has come down significantly from a mid-September peak of 90,000 plus cases daily and its fatality rate is lower than other badly affected countries.
Britain and Argentina this week authorised the AstraZeneca vaccine while the World Health Organization on Thursday granted emergency validation to the rival Pfizer-BioNTech vaccine. Covishield is expected to get more use in India as it can be stored and transported under normal refrigeration while the Pfizer shot needs ultra-low temperatures for storage.